# Balchem Corporation > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Balchem Corporation). ## Overview Balchem Corp develops, manufactures, distributes, and markets specialty performance ingredients and products used in human nutrition, animal nutrition, food and beverage, pharmaceutical, plant nutrition, sterilization, fumigation, and industrial applications. The company is organized around three reportable segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products, with a small amount of other and unallocated activity. Its products are sold through a mix of direct sales, independent distributors, and sales agents, which supports both branded ingredient relationships and broader market reach. Balchem’s business is built around formulation know-how, application support, and manufacturing capabilities in specialized ingredients rather than commodity chemicals. The company was incorporated in Maryland in 1967 and has expanded through ongoing investment in production facilities, intangible assets, and selective acquisitions. ## Products & services • Human-grade choline nutrients and mineral amino acid chelates • Specialty vitamin K2 and MSM nutritional ingredients • Food and beverage ingredient systems and solutions • Animal nutrition and health ingredients, including choline chloride • Performance gases and plant nutrition products • Sterilization and fumigation products • Industrial specialty products and toll manufacturing - **Human Nutrition and Health** (62%) — Choline nutrients, mineral chelates, vitamin K2, MSM, and food ingredient solutions for human nutrition and food and beverage applications. - **Animal Nutrition and Health** (22%) — Feed and animal health ingredients, including choline chloride and related nutritional products for livestock and other animal markets. - **Specialty Products** (14%) — Performance gases, plant nutrition, sterilization, fumigation, and other industrial specialty products and services. - **Other and Unallocated** (2%) — Minor business activities and sales not assigned to the reportable segments. - Human-grade choline nutrients for nutrition and health applications - Mineral amino acid chelates, mineral salts, and mineral complexes - Specialty vitamin K2 and MSM ingredients - Food and beverage ingredient systems for beverages, bakery, dairy, confectionery, and savory - Animal nutrition ingredients, including choline chloride - Performance gases, plant nutrition, sterilization, fumigation, and industrial products - Toll manufacturing and customized formulation/manufacturing services ## Customers Balchem sells to manufacturers and formulators that need specialty ingredients with specific functional or nutritional performance. In human nutrition, customers include supplement brands, food and beverage manufacturers, and ingredient formulators that use Balchem’s choline, mineral, vitamin K2, and MSM products in finished goods. In animal nutrition, customers are feed producers and animal health companies that buy ingredients to improve feed formulation and animal performance. Specialty Products serves industrial and plant nutrition customers that need performance gases, fumigation, sterilization, and related specialty chemical solutions. The company’s customer relationships depend on product performance, technical support, quality, and regulatory/compliance credibility, which is especially important in nutrition and food applications. - **Human nutrition and supplement manufacturers** (primary) — They buy choline nutrients, mineral chelates, vitamin K2, and MSM to formulate dietary supplements and nutrition products with scientific and brand differentiation. - **Food and beverage manufacturers** (primary) — They buy ingredient systems and customized solutions for beverages, bakery, dairy, confectionery, savory, and related applications to improve functionality and speed commercialization. - **Animal nutrition and feed producers** (secondary) — They buy choline chloride and related feed ingredients to improve animal nutrition, formulation efficiency, and performance outcomes. - **Industrial and plant nutrition customers** (secondary) — They buy performance gases, fumigation, sterilization, and plant nutrition products for operational and agronomic use cases. - Supplement brands and ingredient formulators buying choline, minerals, K2, and MSM - Food and beverage manufacturers needing functional ingredient systems - Animal feed and animal health customers using choline chloride and feed ingredients - Industrial and plant nutrition customers buying specialty gases and treatment products - Customers that value technical support, product quality, and application testing - Buyers seeking differentiated ingredients rather than commodity inputs ## Geography Balchem is a U.S.-based company, but its operations and sales extend outside the United States, and management explicitly notes exposure from sales to customers and manufacturing operations abroad. The company holds a meaningful amount of cash in foreign subsidiaries and intends to reinvest it in foreign operations, plant investments, and potential acquisitions, which indicates an international operating footprint. The European Union is strategically important because the company has been involved in anti-dumping proceedings related to choline chloride imports from China, highlighting regulatory and trade exposure in that market. While the excerpts do not provide a country-by-country revenue split, they show that foreign operations and cross-border trade are material to the business model. Geography matters because Balchem’s ingredients are sold into global nutrition and industrial supply chains, and trade duties, foreign tax rates, and local manufacturing decisions can affect margins and supply continuity. - U.S.-headquartered with sales and manufacturing exposure outside the United States - Foreign subsidiaries hold a meaningful share of cash and support reinvestment abroad - European Union trade policy is relevant due to choline chloride anti-dumping duties - International operations affect tax rates, logistics, and capital allocation - Global customer base spans nutrition, food, animal health, and industrial markets ## Strategy Balchem’s strategy centers on growing differentiated specialty ingredients and solutions across its three core segments. The company is investing in production facilities, corporate projects, and intangible assets to support capacity, product development, and manufacturing efficiency. It also continues to pursue acquisition candidates, suggesting a disciplined bolt-on M&A strategy to add capabilities or capacity. In human nutrition and food applications, the company emphasizes scientific data, intellectual property, and brand value to defend against lower-cost competitors. In specialty and animal nutrition markets, service, reliability, quality, and customer support remain central to maintaining share in price-competitive categories. - **Capacity and facility investment** (short-term) — Additional production capacity and process improvements support growth, reliability, and cost control in specialty ingredients. - **Product differentiation in human nutrition** (medium-term) — Scientific data, intellectual property, and brand value help protect margins against lower-cost competitors. - **Selective acquisitions** (medium-term) — Acquisitions can add capacity, technology, or market access and broaden the specialty ingredient platform. - Invest in production facilities and intangible assets to support growth - Use scientific data and IP to differentiate human nutrition products - Expand food and beverage solutions through application support and commercialization - Pursue acquisitions to add capacity or capabilities - Maintain service, reliability, and quality in price-competitive markets - Support growth with internal cash flow and selective borrowing ## Risks Balchem faces competitive pressure in markets that are often highly price competitive, especially in animal feed, industrial, and ingredient applications. Its human nutrition and food businesses depend on consumer and customer confidence in product safety, quality, and dietary benefits, so any contamination issue, recall, or negative publicity could reduce demand. The company also has meaningful exposure to foreign operations, trade policy, and regulatory actions, as shown by the EU anti-dumping duties on choline chloride from China. Sustainability, ESG, and reputational expectations create additional risk because perceived failures can affect brand trust and customer relationships. As a specialty ingredients company, Balchem is also exposed to raw material, manufacturing, and innovation risk, since customers can switch to substitutes or lower-cost alternatives if performance or service weakens. - **Price competition in animal nutrition and industrial markets** [high] — Customers can compare Balchem’s ingredients against lower-cost alternatives, limiting pricing power. - **Product quality, safety, or recall events** [high] — Nutrition and food customers rely on safety and performance claims, so adverse events can quickly reduce demand. - **Foreign operations and trade/regulatory exposure** [high] — The company sells and manufactures outside the U.S., and EU duties on choline chloride show how policy can affect economics. - **Goodwill and intangible asset impairment** [medium] — Acquisitions and acquired intangibles require judgment on future cash flows and discount rates, which can lead to write-downs if performance weakens. - **ESG and reputational risk** [medium] — Stakeholder expectations around sustainability, emissions, water use, and workplace conduct can affect brand perception and customer retention. - Highly price-competitive markets can pressure margins and share - Product quality or safety issues could damage customer and consumer trust - Foreign operations create exposure to tax, regulatory, and geopolitical changes - EU anti-dumping duties and trade actions can disrupt sourcing and sales - Sustainability and ESG expectations can create reputational risk - Substitute products and alternate technologies can erode demand - Acquisition integration and capacity expansion carry execution risk ## Accounting Balchem’s reported results are sensitive to judgment in goodwill and intangible asset valuation, because the company has acquired businesses and intangible assets whose recoverability depends on future cash flows and discount rates. Management explicitly notes that changes in market conditions, laws, regulations, competitive factors, and assumptions could trigger impairment charges, which would affect earnings and equity. Revenue is driven by a mix of direct sales, distributors, and agents across multiple end markets, so investors should watch for quarter-to-quarter mix changes, pricing effects, and foreign currency impacts rather than assuming linear growth. The company also has foreign cash balances that it intends to permanently reinvest, which can affect tax accounting and repatriation assumptions. In addition, stock repurchases, dividends, debt usage, and acquisition accounting can change reported leverage, equity, and future amortization expense. - **Goodwill and intangible asset impairment** — Can materially affect earnings and balance sheet carrying values - **Foreign cash and permanent reinvestment** — Can affect tax expense and liquidity analysis - **Revenue mix and channel timing** — Can distort quarter-to-quarter comparability - **Acquisition accounting and amortization** — Can affect operating profit and reported margins - Goodwill and intangible asset impairment depends on future cash flow assumptions - Acquisition accounting can create amortization and valuation judgments - Foreign cash and permanent reinvestment assertions affect tax accounting - Revenue mix across segments and channels can create quarterly variability - Foreign currency movements can affect reported sales growth - Share repurchases, dividends, and borrowing affect capital structure presentation --- *Last updated: 2026-08-11T04:46:21.944236+00:00*